Justin Cates, M.D., Ph.D.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours? Numbere N, Huber AR, Shi C, Cates JMM, Gonzalez RS (2019) Histopathology 74(3): 424-429
   › Primary publication · 30326145 (PubMed)
2. Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component. Gonzalez RS, Cates JMM, Washington K (2019) Histopathology 74(3): 406-414
   › Primary publication · 30160323 (PubMed) · PMC6450535 (PubMed Central)
3. AJCC eighth edition for soft tissue sarcoma of the extremities and trunk. Cates JMM (2018) Ann Oncol 29(9): 2023
   › Primary publication · 30016394 (PubMed)
4. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors. Gonzalez RS, Cates JMM, Shi C (2018) Mod Pathol 31(10): 1560-1566
   › Primary publication · 29795438 (PubMed)
5. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. Gibson WE, Gonzalez RS, Cates JMM, Liu E, Shi C (2018) Hum Pathol : 109-115
   › Primary publication · 29763717 (PubMed) · PMC6133739 (PubMed Central)
6. Simple staging system for osteosarcoma performs equivalently to the AJCC and MSTS systems. Cates JMM (2018) J Orthop Res 36(10): 2802-2808
   › Primary publication · 29718558 (PubMed)
7. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers. Wang Y, Vnencak-Jones CL, Cates JM, Shi C (2018) J Mol Diagn 20(3): 366-372
   › Primary publication · 29474982 (PubMed) · PMC5966712 (PubMed Central)
8. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database. Cates JMM (2018) J Natl Compr Canc Netw 16(2): 144-152
   › Primary publication · 29439175 (PubMed)
9. Aneurysmal Bone Cyst of the Scaphoid: A Case Report. Lebus GF, Cates JM, Lee DH (2016) JBJS Case Connect 6(2): e49
   › Primary publication · 29252681 (PubMed)
10. Modeling Continuous Prognostic Factors in Survival Analysis: Implications for Tumor Staging and Assessing Chemotherapy Effect in Osteosarcoma. Cates JMM (2018) Am J Surg Pathol 42(4): 485-491
    › Primary publication · 29200101 (PubMed)
11. Gastric Carcinomas With Lymphoid Stroma: Categorization and Comparison With Solid-Type Colonic Carcinomas. Gonzalez RS, Cates JMM, Revetta F, McMahon LA, Washington K (2017) Am J Clin Pathol 148(6): 477-484
    › Primary publication · 29126141 (PubMed) · PMC6543885 (PubMed Central)
12. Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival. Cates JMM (2017) Ann Surg Oncol 24(13): 3880-3887
    › Primary publication · 29058143 (PubMed)
13. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors. Nohr E, Lee LH, Cates JM, Perizzolo M, Itani D (2017) Hum Pathol : 119-127
    › Primary publication · 28882701 (PubMed)
14. Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis. Janssen ML, van Broekhoven DL, Cates JM, Bramer WM, Nuyttens JJ, Gronchi A, Salas S, Bonvalot S, Grünhagen DJ, Verhoef C (2017) Br J Surg 104(4): 347-357
    › Primary publication · 28199014 (PubMed)
15. Comparison of the AJCC, MSTS, and Modified Spanier Systems for Clinical and Pathologic Staging of Osteosarcoma. Cates JM (2017) Am J Surg Pathol 41(3): 405-413
    › Primary publication · 28195881 (PubMed)
16. Reporting Surgical Resection Margin Status for Osteosarcoma: Comparison of the AJCC, MSTS, and Margin Distance Methods. Cates JM (2017) Am J Surg Pathol 41(5): 633-642
    › Primary publication · 28125453 (PubMed)
17. Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling. Polosukhin VV, Richmond BW, Du RH, Cates JM, Wu P, Nian H, Massion PP, Ware LB, Lee JW, Kononov AV, Lawson WE, Blackwell TS (2017) Am J Respir Crit Care Med 195(8): 1010-1021
    › Primary publication · 27911098 (PubMed) · PMC5422646 (PubMed Central)
18. Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer. Arnold Egloff SA, Du L, Loomans HA, Starchenko A, Su PF, Ketova T, Knoll PB, Wang J, Haddad AQ, Fadare O, Cates JM, Lotan Y, Shyr Y, Clark PE, Zijlstra A (2017) Oncotarget 8(1): 722-741
    › Primary publication · 27894096 (PubMed) · PMC5352192 (PubMed Central)
19. Myopericytoma of the Internal Auditory Canal. Hunter JB, O'Connell BP, Chow WN, Weaver KD, Cates JM, Wanna GB (2017) Otol Neurotol 38(2): e5-e7
    › Primary publication · 27832007 (PubMed)
20. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis. Fata CR, Gonzalez RS, Liu E, Cates JM, Shi C (2017) Am J Surg Pathol 41(1): 128-133
    › Primary publication · 27684993 (PubMed) · PMC5159256 (PubMed Central)
21. Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade. Johnson DB, Frampton GM, Rioth MJ, Yusko E, Xu Y, Guo X, Ennis RC, Fabrizio D, Chalmers ZR, Greenbowe J, Ali SM, Balasubramanian S, Sun JX, He Y, Frederick DT, Puzanov I, Balko JM, Cates JM, Ross JS, Sanders C, Robins H, Shyr Y, Miller VA, Stephens PJ, Sullivan RJ, Sosman JA, Lovly CM (2016) Cancer Immunol Res 4(11): 959-967
    › Primary publication · 27671167 (PubMed) · PMC5134329 (PubMed Central)
22. Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template. Cates JM, Dupont WD (2017) Mod Pathol 30(1): 52-59
    › Primary publication · 27658478 (PubMed)
23. Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo. Yang S, Jiang M, Grabowska MM, Li J, Connelly ZM, Zhang J, Hayward SW, Cates JM, Han G, Yu X (2016) Oncotarget 7(43): 70404-70419
    › Primary publication · 27611945 (PubMed) · PMC5342561 (PubMed Central)
24. Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition. Gonzalez RS, Huh WJ, Cates JM, Washington K, Beauchamp RD, Coffey RJ, Shi C (2017) Histopathology 70(2): 223-231
    › Primary publication · 27560620 (PubMed) · PMC5921077 (PubMed Central)
25. Utility of Examination of Biopsy Tracts in Osteosarcoma Resection Specimens. Cates JM (2016) Am J Clin Pathol 146(3): 324-7
    › Primary publication · 27543978 (PubMed)
26. Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression. Qiao J, Grabowska MM, Forestier-Roman IS, Mirosevich J, Case TC, Chung DH, Cates JM, Matusik RJ, Manning HC, Jin R (2016) Oncotarget 7(38): 61955-61969
    › Primary publication · 27542219 (PubMed) · PMC5308703 (PubMed Central)
27. Plasmin Prevents Dystrophic Calcification After Muscle Injury. Mignemi NA, Yuasa M, Baker CE, Moore SN, Ihejirika RC, Oelsner WK, Wallace CS, Yoshii T, Okawa A, Revenko AS, MacLeod AR, Bhattacharjee G, Barnett JV, Schwartz HS, Degen JL, Flick MJ, Cates JM, Schoenecker JG (2017) J Bone Miner Res 32(2): 294-308
    › Primary publication · 27530373 (PubMed)
28. Validation of a Radiography-Based Quantification Designed to Longitudinally Monitor Soft Tissue Calcification in Skeletal Muscle. Moore SN, Hawley GD, Smith EN, Mignemi NA, Ihejirika RC, Yuasa M, Cates JM, Liu X, Schoenecker JG (2016) PLoS One 11(7): e0159624
    › Primary publication · 27438007 (PubMed) · PMC4954695 (PubMed Central)
29. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients. Cates JM, Schoenecker JG (2016) Acta Oncol 55(8): 1036-9
    › Primary publication · 27145235 (PubMed)
30. Pathologic fracture a poor prognostic factor in osteosarcoma: Misleading conclusions from meta-analyses? Cates JM (2016) Eur J Surg Oncol 42(6): 883-8
    › Primary publication · 26895688 (PubMed)
31. Osteosarcoma: Differential Diagnostic Considerations. Gonzalez AL, Cates JM (2012) Surg Pathol Clin 5(1): 117-46
    › Primary publication · 26837918 (PubMed)
32. EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer. Amato KR, Wang S, Tan L, Hastings AK, Song W, Lovly CM, Meador CB, Ye F, Lu P, Balko JM, Colvin DC, Cates JM, Pao W, Gray NS, Chen J (2016) Cancer Res 76(2): 305-18
    › Primary publication · 26744526 (PubMed) · PMC4715957 (PubMed Central)
33. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia. Grabowska MM, Kelly SM, Reese AL, Cates JM, Case TC, Zhang J, DeGraff DJ, Strand DW, Miller NL, Clark PE, Hayward SW, Gronostajski RM, Anderson PD, Matusik RJ (2016) Endocrinology 157(3): 1094-109
    › Primary publication · 26677878 (PubMed) · PMC4769366 (PubMed Central)
34. Genetic determinants of fibro-osseous lesions in aged inbred mice. Berndt A, Ackert-Bicknell C, Silva KA, Kennedy VE, Sundberg BA, Cates JM, Schofield PN, Sundberg JP (2016) Exp Mol Pathol 100(1): 92-100
    › Primary publication · 26589134 (PubMed) · PMC4766837 (PubMed Central)
35. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME (2016) Histopathology 68(7): 1040-5
    › Primary publication · 26542423 (PubMed)
36. Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease. Du RH, Richmond BW, Blackwell TS, Cates JM, Massion PP, Ware LB, Lee JW, Kononov AV, Lawson WE, Blackwell TS, Polosukhin VV (2015) Virchows Arch 467(6): 657-665
    › Primary publication · 26432569 (PubMed) · PMC5081073 (PubMed Central)
37. Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. Yuasa M, Mignemi NA, Nyman JS, Duvall CL, Schwartz HS, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible JE, Obremskey WT, Flick MJ, Degen JL, Barnett JV, Cates JM, Schoenecker JG (2015) J Clin Invest 125(9): 3723
    › Primary publication · 26325037 (PubMed) · PMC4588290 (PubMed Central)
38. Inhibition of Wnt/β-catenin pathway promotes regenerative repair of cutaneous and cartilage injury. Bastakoty D, Saraswati S, Cates J, Lee E, Nanney LB, Young PP (2015) FASEB J 29(12): 4881-92
    › Primary publication · 26268926 (PubMed) · PMC4653050 (PubMed Central)
39. Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. Yuasa M, Mignemi NA, Nyman JS, Duvall CL, Schwartz HS, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible JE, Obremskey WT, Flick MJ, Degen JL, Barnett JV, Cates JM, Schoenecker JG (2015) J Clin Invest 125(8): 3117-31
    › Primary publication · 26214526 (PubMed) · PMC4563750 (PubMed Central)
40. Differential diagnostic considerations of desmoid-type fibromatosis. Goldstein JA, Cates JM (2015) Adv Anat Pathol 22(4): 260-6
    › Primary publication · 26050263 (PubMed)
41. Granular cell tumors overexpress TFE3 without corollary gene rearrangement--Reply. Chamberlain BK, McClain CM, Gonzalez RS, Coffin CM, Cates JM (2015) Hum Pathol 46(8): 1243
    › Primary publication · 26001332 (PubMed)
42. Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma. Cates JM, Memoli VA, Gonzalez RS (2015) Virchows Arch 467(2): 211-6
    › Primary publication · 25940995 (PubMed)
43. Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis. Cates JM (2015) Pathol Oncol Res 21(4): 1085-90
    › Primary publication · 25916970 (PubMed)
44. Adenoma-like adenocarcinoma: a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation. Gonzalez RS, Cates JM, Washington MK, Beauchamp RD, Coffey RJ, Shi C (2016) Histopathology 68(2): 183-90
    › Primary publication · 25913616 (PubMed) · PMC4619179 (PubMed Central)
45. Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer. Reddy OL, Cates JM, Gellert LL, Crist HS, Yang Z, Yamashita H, Taylor JA, Smith JA, Chang SS, Cookson MS, You C, Barocas DA, Grabowska MM, Ye F, Wu XR, Yi Y, Matusik RJ, Kaestner KH, Clark PE, DeGraff DJ (2015) Am J Pathol 185(5): 1385-95
    › Primary publication · 25907831 (PubMed) · PMC4419202 (PubMed Central)
46. Surgical resection margins in desmoid-type fibromatosis: a critical reassessment. Cates JM, Stricker TP (2014) Am J Surg Pathol 38(12): 1707-14
    › Primary publication · 25392923 (PubMed)
47. Quality Management of the Immunohistochemistry Laboratory: A Practical Guide. Cates JM, Troutman KA (2015) Appl Immunohistochem Mol Morphol 23(7): 471-80
    › Primary publication · 25203427 (PubMed)
48. Pregnancy does not increase the local recurrence rate after surgical resection of desmoid-type fibromatosis. Cates JM (2015) Int J Clin Oncol 20(3): 617-22
    › Primary publication · 25124238 (PubMed)
49. SOX2 expression in the developing, adult, as well as, diseased prostate. Yu X, Cates JM, Morrissey C, You C, Grabowska MM, Zhang J, DeGraff DJ, Strand DW, Franco OE, Lin-Tsai O, Hayward SW, Matusik RJ (2014) Prostate Cancer Prostatic Dis 17(4): 301-9
    › Primary publication · 25091041 (PubMed) · PMC4227931 (PubMed Central)
50. Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence. Cates JM, Stricker TP, Sturgeon D, Coffin CM (2014) Cancer Lett 353(2): 176-81
    › Primary publication · 25064609 (PubMed)
51. The temporal and spatial development of vascularity in a healing displaced fracture. Yuasa M, Mignemi NA, Barnett JV, Cates JM, Nyman JS, Okawa A, Yoshii T, Schwartz HS, Stutz CM, Schoenecker JG (2014) Bone : 208-21
    › Primary publication · 25016962 (PubMed)
52. Occult primary, version 3.2014. Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA, National Comprehensive Cancer Network (2014) J Natl Compr Canc Netw 12(7): 969-74
    › Primary publication · 24994917 (PubMed)
53. Micro-computed tomography derived anisotropy detects tumor provoked deviations in bone in an orthotopic osteosarcoma murine model. Cole HA, Ohba T, Ichikawa J, Nyman JS, Cates JM, Haro H, Schwartz HS, Schoenecker JG (2014) PLoS One 9(6): e97381
    › Primary publication · 24892952 (PubMed) · PMC4043681 (PubMed Central)
54. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype. DeGraff DJ, Grabowska MM, Case TC, Yu X, Herrick MK, Hayward WJ, Strand DW, Cates JM, Hayward SW, Gao N, Walter MA, Buttyan R, Yi Y, Kaestner KH, Matusik RJ (2014) Lab Invest 94(7): 726-39
    › Primary publication · 24840332 (PubMed) · PMC4451837 (PubMed Central)
55. Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma. Ohba T, Cates JM, Cole HA, Slosky DA, Haro H, Ando T, Schwartz HS, Schoenecker JG (2014) Mol Cancer Res 12(8): 1100-11
    › Primary publication · 24759089 (PubMed)
56. Alveolar soft part sarcoma and granular cell tumor: an immunohistochemical comparison study. Chamberlain BK, McClain CM, Gonzalez RS, Coffin CM, Cates JM (2014) Hum Pathol 45(5): 1039-44
    › Primary publication · 24746209 (PubMed)
57. Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC. Amato KR, Wang S, Hastings AK, Youngblood VM, Santapuram PR, Chen H, Cates JM, Colvin DC, Ye F, Brantley-Sieders DM, Cook RS, Tan L, Gray NS, Chen J (2014) J Clin Invest 124(5): 2037-49
    › Primary publication · 24713656 (PubMed) · PMC4001547 (PubMed Central)
58. Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Cole HA, Ohba T, Nyman JS, Hirotaka H, Cates JM, Flick MJ, Degen JL, Schoenecker JG (2014) Arthritis Rheumatol 66(8): 2222-33
    › Primary publication · 24664548 (PubMed) · PMC4474376 (PubMed Central)
59. Pleiotropic effects of bisphosphonates on osteosarcoma. Ohba T, Cates JM, Cole HA, Slosky DA, Haro H, Ichikawa J, Ando T, Schwartz HS, Schoenecker JG (2014) Bone : 110-20
    › Primary publication · 24636958 (PubMed)
60. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. Ohba T, Cole HA, Cates JM, Slosky DA, Haro H, Ando T, Schwartz HS, Schoenecker JG (2014) J Bone Miner Res 29(6): 1431-45
    › Primary publication · 24443409 (PubMed)
61. Differential development of the distal and proximal femoral epiphysis and physis in mice. Cole HA, Yuasa M, Hawley G, Cates JM, Nyman JS, Schoenecker JG (2013) Bone 52(1): 337-46
    › Primary publication · 23079139 (PubMed)
62. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors. Mignemi NA, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Correa H, Coffin CM, Black JO, Yi Y, Halpern JL, Holt GE, Schwartz HS, Schoenecker JG, Cates JM (2012) Cancer Sci 103(12): 2173-80
    › Primary publication · 23035734 (PubMed) · PMC4278584 (PubMed Central)
63. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Pruitt FL, He Y, Franco OE, Jiang M, Cates JM, Hayward SW (2013) Prostate 73(5): 476-88
    › Citation · 22996917 (PubMed) · PMC3594371 (PubMed Central)
64. Nuclear p63 expression in osteoblastic tumors. Kallen ME, Sanders ME, Gonzalez AL, Black JO, Keedy VL, Hande KR, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Cates JM (2012) Tumour Biol 33(5): 1639-44
    › Citation · 22623071 (PubMed)
65. Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases. Cates JM, Black JO, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM (2012) Hum Pathol 43(10): 1711-8
    › Primary publication · 22520949 (PubMed) · PMC4278590 (PubMed Central)
66. Extraskeletal cartilaginous, osseous, and chordoid tumors in children and adolescents. Cates JM, Coffin CM (2012) Pediatr Dev Pathol 15(1 Suppl): 255-66
    › Primary publication · 22420731 (PubMed)
67. Neurogenic tumors of soft tissue. Cates JM, Coffin CM (2012) Pediatr Dev Pathol 15(1 Suppl): 62-107
    › Primary publication · 22420725 (PubMed)
68. Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy. Cates JM, Black J, Wolfe CC, Shinohara ET, Holt GE, Keedy VL, Hande KR, Homlar KC, Halpern JL, Schwartz HS, Troutman A, Coffin CM (2012) Hum Pathol 43(9): 1418-24
    › Primary publication · 22404950 (PubMed)
69. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma. Rosado FG, Itani DM, Coffin CM, Cates JM (2012) Arch Pathol Lab Med 136(3): 301-4
    › Primary publication · 22372906 (PubMed)
70. Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall. Kallen ME, Nunes Rosado FG, Gonzalez AL, Sanders ME, Cates JM (2012) Pathol Oncol Res 18(1): 97-100
    › Primary publication · 21667345 (PubMed)
71. The sonic hedgehog pathway in chordoid tumours. Cates JM, Itani DM, Coffin CM, Harfe BD (2010) Histopathology 56(7): 978-9
    › Primary publication · 20500228 (PubMed)
72. Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis. Cates JM, Friedman DB, Seeley EH, Dupont WD, Schwartz HS, Holt GE, Caprioli RM, Young PP (2010) Int J Exp Pathol 91(4): 335-49
    › Primary publication · 20353421 (PubMed) · PMC2962892 (PubMed Central)
73. Foamy cell angiosarcoma: a rare and deceptively bland variant of cutaneous angiosarcoma. Tatsas AD, Keedy VL, Florell SR, Simpson JF, Coffin CM, Kelley MC, Cates JM (2010) J Cutan Pathol 37(8): 901-6
    › Primary publication · 20175826 (PubMed)
74. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Kelley MJ, Cates JM (2010) J Pathol 220(5): 608-17
    › Primary publication · 20140939 (PubMed)
75. Primary leiomyosarcoma of extragnathic bone: clinicopathologic features and reevaluation of prognosis. Adelani MA, Schultenover SJ, Holt GE, Cates JM (2009) Arch Pathol Lab Med 133(9): 1448-56
    › Primary publication · 19722754 (PubMed)
76. Cyclooxygenase 2 expression in soft tissue leiomyosarcoma. Herceg ME, Tsiatis AC, Halpern JL, Holt GE, Schwartz HS, Keedy VL, Cates JM (2009) Anticancer Res 29(8): 2913-7
    › Primary publication · 19661295 (PubMed)
77. Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma. Tsiatis AC, Herceg ME, Keedy VL, Halpern JL, Holt GE, Schwartz HS, Cates JM (2009) Mod Pathol 22(11): 1432-8
    › Primary publication · 19633646 (PubMed)
78. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Cates JM, Byrd RH, Fohn LE, Tatsas AD, Washington MK, Black CC (2009) Pancreas 38(1): e1-6
    › Primary publication · 18766116 (PubMed) · PMC2882851 (PubMed Central)
79. Markers of epithelial-mesenchymal transition and epithelial differentiation in sarcomatoid carcinoma: utility in the differential diagnosis with sarcoma. Cates JM, Dupont WD, Barnes JW, Edmunds HS, Fasig JH, Olson SJ, Black CC (2008) Appl Immunohistochem Mol Morphol 16(3): 251-62
    › Primary publication · 18301244 (PubMed)
80. Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature. Tsiatis AC, Atkinson JB, Wright JK, Cates JM (2008) Ultrastruct Pathol 32(1): 25-8
    › Primary publication · 18300035 (PubMed)
81. Inflammatory myofibroblastic tumor of the urinary bladder in a 27-year-old woman with systemic lupus erythematosus. Hoene KA, Kaufman MR, Cates JM, Chang SS (2008) Int J Urol 15(2): 182-4
    › Primary publication · 18269462 (PubMed)
82. Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma. Fasig JH, Dupont WD, LaFleur BJ, Olson SJ, Cates JM (2008) Neuropathol Appl Neurobiol 34(1): 95-104
    › Primary publication · 17973908 (PubMed)
83. Steroid hormone receptor and COX-2 expression in chordoma. Fasig JH, Dupont WD, Olson SJ, Lafleur BJ, Cates JM (2007) Am J Clin Pathol 128(3): 375-81
    › Primary publication · 17709310 (PubMed)
84. Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome. Pitchford CW, Schwartz HS, Atkinson JB, Cates JM (2006) Am J Surg Pathol 30(12): 1624-9
    › Primary publication · 17122521 (PubMed)
85. Calretinin expression in tumors of adipose tissue. Cates JM, Coffing BN, Harris BT, Black CC (2006) Hum Pathol 37(3): 312-21
    › Primary publication · 16613326 (PubMed)
86. Intraductal papillary mucinous adenoma that arises from pancreatic heterotopia within a meckel diverticulum. Cates JM, Williams TL, Suriawinata AA (2005) Arch Pathol Lab Med 129(3): e67-9
    › Primary publication · 15737052 (PubMed)
87. Chondroblastoma-like chondroma of soft tissue: an underrecognized variant and its differential diagnosis. Cates JM, Rosenberg AE, O'Connell JX, Nielsen GP (2001) Am J Surg Pathol 25(5): 661-6
    › Primary publication · 11342780 (PubMed)
88. Characterization and developmental expression patterns of testicular androgen-binding protein in the Djungarian hamster (Phodopus sungorus). Cates JM, Damassa DA (1997) J Reprod Fertil 111(2): 291-8
    › Primary publication · 9462298 (PubMed)
89. Sex hormone-binding globulin and male sexual development. Damassa DA, Cates JM (1995) Neurosci Biobehav Rev 19(2): 165-75
    › Primary publication · 7630573 (PubMed)
90. Hepatic expression of sex hormone-binding globulin associated with the postnatal surge of serum androgen-binding activity in the Djungarian hamster. Cates JM, Damassa DA, Gagin GA, Dempsey RV (1995) J Steroid Biochem Mol Biol 55(2): 147-58
    › Primary publication · 7495693 (PubMed)

View full member profile

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword